Metabolomics in Drug Discovery

Metabolomics is being used in Drug Discovery and in development from lead compound discovery to post approval drug surveillance. Metabolomics can help in finding potential new sites for therapeutic intervention by identifying metabolic changes. Metabolomics can provide activity information about possible novel drugs and drug scaffolds, indicate interesting targets for drug development and suggest binding partners of compounds. Furthermore, metabolomics can be used for the discovery of novel natural products and in drug development. Metabolomics can enhance the discovery and testing of new drugs and provide insight into the on- and off-target effects of drugs.

  • Drug metabolism during drug design and development
  • Metabolites in identification of drug targets
  • Metabonomics in preclinical pharmaceutical discovery and development
  • Toxicology and drug metabolism
  • QSAR and ligand-receptor models
  • Applications in Drug Development

Related Conference of Metabolomics in Drug Discovery

April 16-17, 2020

16th World Congress on Structural Biology

Amsterdam, Netherlands
April 20-21, 2020

11th Tissue Science and Regeneration Congress

Kuala Lumpur, Malaysia
June 28-30 2020

globalbiotechnology-cs-2020

June 28-30 2020

oilgas-cs-2020

June 28-30 2020

BEHAVIOURAL SCIENCE-2020

June 28-30 2020

Bioinfo 2020

July 17-18, 2020

10th Glycobiology World Congress

Vienna, Austria
August 04,05 2020

12th Euro Biosensors & Bioelectronics Congress

Zurich, Switzerland
June 28-30 2020

NURSE PRACTITIONER 2020

September 28-29, 2020

19th International Conference on Structural Biology

Barcelona, Spain
October 14-15, 2020

9th World Congress on Glycobiology & Glycochemistry

Rome, Italy
December 10-11, 2020

2nd European Pathology and Infectious Disease Conference

Abu Dhabi, UAE

Metabolomics in Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in